What is immunomodulatory therapy?

Immunomodulatory therapy consists of a number of three types of treatment procedures in diseases that suffer from the human immune system, and is more often referred to as immunotherapy. Three types of immunomodulatory therapy strategies include the use of immunosuppressive drugs to expand the natural effect of the immune system, or the use of immunostimulatory drugs to increase its response and tolelerogens that condition the immune system to tolerate tissue such as transplanted organs. Each treatment class is designed for specific problems of the immune system. Immunosuppressive drugs and tolelerogens are used together to treat autoimmune diseases such as multiple sclerosis (MS) and organ transplantation where the body attacks its own tissue. Immunimulatory drugs are administered to increase the immune system in cases where it is weakened, such as cancer, AIDS and other life -threatening infections.

In cases where immunomodulatory therapy is used in an immunosuppressive role, the therapy F itself mayUngovat somewhat in the dark. With multiple sclerosis, it is still little understood about pathogenesis or the establishment and development of the disease over time. The role of the role of immunomodulatory therapy itself in alleviating some suffering is also misunderstood, but treatment was the only available method that helps patients with MS in 2004. Because of the benefits offering chronically ill patients, immunomodulatory therapy consisting of four immunomodulatory drugs. In patients who are more common in patients, the fact that it is in patients in patients who are in patients in patients, in 1993 patients. American food and drug administration (FDA), although complete understanding of how they work is unclear.

For immunostimulatory and immunosuppressive therapy, it is a prerequisite that the wide effects on the immune system will have a generally useful result to treat any condition. The idea is such thatSuch immunomodulatory therapy, which is non -specific stimulating the human immune system, although doctors and scientists have not been able to trace direct results and effects from 2011. Support for continuing such treatment was entirely based on empirical evidence and evidence of experience and evidence of their learning and learning.

.

Given this empirical approach with immunomodulatory therapy, there has been a medical area about whether such approaches are indeed guaranteed. This is especially true for the treatment of social animals, such as recurring skin diseases where immunontimulatory drugs are prescribed. Such conditions may have the basic causes that are not based on a failureimal system. If the treatment is suspended, the condition may return and the cycle will have to continue again because it was not due to immunodeficiency in the first place.